{"id":10375,"date":"2022-12-16T07:42:11","date_gmt":"2022-12-15T22:42:11","guid":{"rendered":"https:\/\/symdfmtcopro.wpenginepowered.com\/post\/10375"},"modified":"2024-01-16T21:39:10","modified_gmt":"2024-01-16T12:39:10","slug":"u-s-fda-approves-first-fecal-microbiota-product","status":"publish","type":"post","link":"https:\/\/fmt-japan.org\/en\/post\/10375","title":{"rendered":"U.S. FDA approves first fecal microbiota product"},"content":{"rendered":" \n

\u00a0<\/p> \n \n

On November 30, 2022, the U.S. Food and Drug Administration (FDA) approved FerringPharma’s fecal microbiota product, Rebyota, for the treatment of rCDI, the first time the FDA has approved a fecal microbiota product.<\/p> \n \n

Rebyota is approved for the prevention of recurrent Clostridioides difficile infection (CDI) in patients 18 years of age and older. The drug is intended for patients 18 years of age and older with recurrent CDI who have completed treatment with antibiotic therapy and is administered as a single rectal dose. The application for Rebyota has been designated and approved as a Breakthrough Therapy, Expedited Approval, and Orphan Drug Application.<\/p> \n \n

This approval represents a step forward in the treatment of patients with recurrent CDI,” said Peter Marks of the FDA’s Center for Biologics Evaluation and Research (CBER).<\/p> \n \n

In this study, approximately 1,000 subjects received Rebyota, and the estimated success rate in preventing recurrent CDI was significantly higher in the Rebyota group (70.6%) than in the placebo group (57.5%).<\/p> \n \n

THE FIRST FDA APPROVAL OF A FECAL MICROBIOTA PRODUCT IS EXPECTED TO ACCELERATE THE DEVELOPMENT OF FMT AS A DRUG.<\/p> \n \n

\u00a0<\/p> \n \n

\u00a0<\/p> \n \n

\u00a0<\/p> \n \n

\u00a0<\/p> \n

\n

Reference Articles<\/strong><\/p> \n \n

FDA News Release\u3010FDA Approves First Fecal Microbiota Product\u30112022.11.30https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-fecal-microbiota-product<\/a><\/p> \n \n

Felling Press Release[Felling Receives U.S. FDA Approval for REBYOTA\u00ae (Fecal Microbiota, live-jslm)– Novel First-in-Class Microbiota-Based Live Biopharmaceutical -] 2022.12.09https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/32\/2022\/12\/08211836\/20221209_pressrelease.pdf<\/a><\/p> \n","protected":false},"excerpt":{"rendered":"On November 30, 2022, the U.S. Food and Drug Administration (FDA) approved FerringPharma’s fecal microbiota product, Rebyota, for the treatment of rCDI, the first time the FDA has approved a fecal microbiota product […","protected":false},"author":1,"featured_media":10376,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[81],"tags":[],"class_list":["post-10375","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\nU.S. FDA approves first fecal microbiota product - \u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. FDA approves first fecal microbiota product - \u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a\" \/>\n<meta property=\"og:description\" content=\"On November 30, 2022, the U.S. Food and Drug Administration (FDA) approved FerringPharma's fecal microbiota product, Rebyota, for the treatment of rCDI, the first time the FDA has approved a fecal microbiota product [...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fmt-japan.org\/post\/9199\" \/>\n<meta property=\"og:site_name\" content=\"\u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-15T22:42:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-16T12:39:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2192\" \/>\n\t<meta property=\"og:image:height\" content=\"1236\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/fmt-japan.org\/post\/9199#article\",\"isPartOf\":{\"@id\":\"https:\/\/fmt-japan.org\/post\/9199\"},\"author\":{\"name\":\"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09\",\"@id\":\"https:\/\/fmt-japan.org\/en\/#\/schema\/person\/13410b392d9464dd0fdd3252124a9ae5\"},\"headline\":\"U.S. FDA approves first fecal microbiota product\",\"datePublished\":\"2022-12-15T22:42:11+00:00\",\"dateModified\":\"2024-01-16T12:39:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fmt-japan.org\/post\/9199\"},\"wordCount\":235,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/fmt-japan.org\/post\/9199#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg\",\"articleSection\":[\"Notices and Activity Reports\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/fmt-japan.org\/post\/9199#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fmt-japan.org\/post\/9199\",\"url\":\"https:\/\/fmt-japan.org\/post\/9199\",\"name\":\"U.S. FDA approves first fecal microbiota product - \u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a\",\"isPartOf\":{\"@id\":\"https:\/\/fmt-japan.org\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fmt-japan.org\/post\/9199#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fmt-japan.org\/post\/9199#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg\",\"datePublished\":\"2022-12-15T22:42:11+00:00\",\"dateModified\":\"2024-01-16T12:39:10+00:00\",\"author\":{\"@id\":\"https:\/\/fmt-japan.org\/en\/#\/schema\/person\/13410b392d9464dd0fdd3252124a9ae5\"},\"breadcrumb\":{\"@id\":\"https:\/\/fmt-japan.org\/post\/9199#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fmt-japan.org\/post\/9199\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fmt-japan.org\/post\/9199#primaryimage\",\"url\":\"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg\",\"contentUrl\":\"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg\",\"width\":2192,\"height\":1236},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fmt-japan.org\/post\/9199#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u30db\u30fc\u30e0\",\"item\":\"https:\/\/fmt-japan.org\/en\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. FDA approves first fecal microbiota product\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fmt-japan.org\/en\/#website\",\"url\":\"https:\/\/fmt-japan.org\/en\/\",\"name\":\"\u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fmt-japan.org\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fmt-japan.org\/en\/#\/schema\/person\/13410b392d9464dd0fdd3252124a9ae5\",\"name\":\"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/7f4724fd34e1039c94ce7ad2df339f0264513e069213dc1a81edf27321668a15?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f4724fd34e1039c94ce7ad2df339f0264513e069213dc1a81edf27321668a15?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f4724fd34e1039c94ce7ad2df339f0264513e069213dc1a81edf27321668a15?s=96&d=mm&r=g\",\"caption\":\"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09\"},\"url\":\"https:\/\/fmt-japan.org\/en\/post\/author\/fmt-japan_admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U.S. FDA approves first fecal microbiota product - \u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"U.S. FDA approves first fecal microbiota product - \u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a","og_description":"On November 30, 2022, the U.S. Food and Drug Administration (FDA) approved FerringPharma's fecal microbiota product, Rebyota, for the treatment of rCDI, the first time the FDA has approved a fecal microbiota product [...","og_url":"https:\/\/fmt-japan.org\/post\/9199","og_site_name":"\u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a","article_published_time":"2022-12-15T22:42:11+00:00","article_modified_time":"2024-01-16T12:39:10+00:00","og_image":[{"width":2192,"height":1236,"url":"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg","type":"image\/jpeg"}],"author":"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fmt-japan.org\/post\/9199#article","isPartOf":{"@id":"https:\/\/fmt-japan.org\/post\/9199"},"author":{"name":"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09","@id":"https:\/\/fmt-japan.org\/en\/#\/schema\/person\/13410b392d9464dd0fdd3252124a9ae5"},"headline":"U.S. FDA approves first fecal microbiota product","datePublished":"2022-12-15T22:42:11+00:00","dateModified":"2024-01-16T12:39:10+00:00","mainEntityOfPage":{"@id":"https:\/\/fmt-japan.org\/post\/9199"},"wordCount":235,"commentCount":0,"image":{"@id":"https:\/\/fmt-japan.org\/post\/9199#primaryimage"},"thumbnailUrl":"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg","articleSection":["Notices and Activity Reports"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fmt-japan.org\/post\/9199#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fmt-japan.org\/post\/9199","url":"https:\/\/fmt-japan.org\/post\/9199","name":"U.S. FDA approves first fecal microbiota product - \u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a","isPartOf":{"@id":"https:\/\/fmt-japan.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fmt-japan.org\/post\/9199#primaryimage"},"image":{"@id":"https:\/\/fmt-japan.org\/post\/9199#primaryimage"},"thumbnailUrl":"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg","datePublished":"2022-12-15T22:42:11+00:00","dateModified":"2024-01-16T12:39:10+00:00","author":{"@id":"https:\/\/fmt-japan.org\/en\/#\/schema\/person\/13410b392d9464dd0fdd3252124a9ae5"},"breadcrumb":{"@id":"https:\/\/fmt-japan.org\/post\/9199#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fmt-japan.org\/post\/9199"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fmt-japan.org\/post\/9199#primaryimage","url":"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg","contentUrl":"https:\/\/fmt-japan.org\/wp-content\/uploads\/2023\/01\/1673647886846@2x.jpg","width":2192,"height":1236},{"@type":"BreadcrumbList","@id":"https:\/\/fmt-japan.org\/post\/9199#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/fmt-japan.org\/en"},{"@type":"ListItem","position":2,"name":"U.S. FDA approves first fecal microbiota product"}]},{"@type":"WebSite","@id":"https:\/\/fmt-japan.org\/en\/#website","url":"https:\/\/fmt-japan.org\/en\/","name":"\u8178\u5185\u30d5\u30ed\u30fc\u30e9\u79fb\u690d\u81e8\u5e8a\u7814\u7a76\u4f1a","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fmt-japan.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fmt-japan.org\/en\/#\/schema\/person\/13410b392d9464dd0fdd3252124a9ae5","name":"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7f4724fd34e1039c94ce7ad2df339f0264513e069213dc1a81edf27321668a15?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7f4724fd34e1039c94ce7ad2df339f0264513e069213dc1a81edf27321668a15?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f4724fd34e1039c94ce7ad2df339f0264513e069213dc1a81edf27321668a15?s=96&d=mm&r=g","caption":"\u30cb\u30c3\u30af\u30cd\u30fc\u30e0\uff08\u5fc5\u9808\uff09"},"url":"https:\/\/fmt-japan.org\/en\/post\/author\/fmt-japan_admin"}]}},"_links":{"self":[{"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/posts\/10375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/comments?post=10375"}],"version-history":[{"count":0,"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/posts\/10375\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/media\/10376"}],"wp:attachment":[{"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/media?parent=10375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/categories?post=10375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fmt-japan.org\/en\/wp-json\/wp\/v2\/tags?post=10375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}